These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer. Iguchi T, Matsuoka J, Sato S, Okumura Y, Omori M, Mifune H, Akaki S, Kanazawa S. Clin Nucl Med; 2007 May; 32(5):361-2. PubMed ID: 17452862 [Abstract] [Full Text] [Related]
8. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography. Low SC, Sinha AK, Sundram FX. Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360 [Abstract] [Full Text] [Related]
15. [Thyroid metastases of pulmonary origin diagnosed by (18)F-FDG PET-CT]. Moragas M, Moreno C, Mourelo S, Soler M, Riera E, García JR. Rev Esp Med Nucl Imagen Mol; 2014 Jun; 33(4):243-4. PubMed ID: 24656755 [No Abstract] [Full Text] [Related]
16. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA. Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819 [Abstract] [Full Text] [Related]
18. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM. Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082 [Abstract] [Full Text] [Related]
19. Uterine leiomyosarcoma metastatic to thyroid shown by 18F-FDG PET/CT imaging. Gauthé M, Testart Dardel N, Nascimento C, Trassard M, Banal A, Alberini JL. Rev Esp Med Nucl Imagen Mol; 2017 Nov; 36(2):113-115. PubMed ID: 27777040 [Abstract] [Full Text] [Related]
20. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma]. Wang GH, Lau EW, Shakher R, Binns DS, Hogg A, Drummond E, Hicks RJ. Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]